The classicsa tribute to the fiftieth anniversary of the randomized clinical trial

Journal of Clinical Epidemiology

Volumn 53, Issue 4, 2000, Pages 335-342

  Fuchs, Flávio D ^a   Klag, Michael J ^b   Whelton, Paul K ^c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; STREPTOMYCIN; ZIDOVUDINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; STUDY; DRUG THERAPY; HISTORY; RESEARCH; REVIEW;

DRUG THERAPY; HISTORY, 20TH CENTURY; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH;

EID: 0033624809     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(99)00185-7     Document Type: Note

References (31)

1. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. 3 ed. St. Louis: Mosby, 1996.
2. Herman J. The demise of the randomized controlled trial. J Clin Epidemiol. 48:1995;985-988.
3. Delay J, Deniker P. Trente-huit cas de psychoses traitées par la cure prolongée et continue de 45660 RP. Le Congrès des Al. Et Neurol de Langue Fr. In, Compte rendu du Congrès. Masson et Cei, Paris, 1952.
4. Phenotiazine treatment in acute schizophrenia. Arch Gen Psychiatry. 10:1964;246-261.
5. Kane J.M., Honigfeld G., Singer J., Meltzer H., the Clozaril Collaborative Study Group Clozapine for the treatment-resistance schizophrenic. results of a US multicenter trial Psychopharmacology (Berlin). 99:1989;S60-S63.
6. Marder S.R., Meibach R.C. Risperidone in the treatment of schizophrenia. Am J Psychiatry. 151:1994;825-835.
7. Finland M. Treatment of bacterial endocarditis. N Engl J Med. 250:1954;372-428.
8. Gonzales R., Sande M. What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Lancet. 345:1995;665-666.
9. Amberson J.B., McMahon B.T., Pinner M. A clinical trial of sanocrysin in pulmonary tuberculosis. Am Rev Tuberc. 24:1931;401-435.
10. Evans W., Hoyle C. Comparative value of drugs used in continuous treatment of angina pectoris. Q J Med. 2:1933;311-338.
11. Greiner T., Gold H., Cattell M.et al. A method of evaluation of the effects of drugs on cardiac pain in patients with angina of effort. Am J Med. 9:1950;143-155.
12. Long-term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet. 2:1982;1173-1180.
13. CASS Principal Investigators Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. N Engl J Med. 310:1974;750-758.
14. Eleven years survival in the Veterans Administration Randomized Trial of Coronary Bypass Surgery for stable angina. N Engl J Med. 311:1984;133-139.
15. Marks J., Truscott B.M., Withycombe J.F. Treatment of venous thrombosis with anticoagulants. review of 1135 cases Lancet. 2:1954;787-791.
16. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressures averaging 90 through 114 mmHg. JAMA 1970;213:1143-52.
17. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-38.
18. MRC Working Party. Medical Research Council Trial of treatment of hypertension in older adults: Br Med J 1992;304:405-12.
19. Dahlöf B., Lindholm L.H., Hansson L., Scherstén B., Ekbom T., Wester P.O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 338:1991;1281-1285.
20. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 265:1991;3255-3264.
21. Frolich E.D., Zanchetti A. Antihypertensive therapy. safety and efficacy of drug and publications Hypertension. 27:1996;317-318.
22. Moore W.S., Barnett H.J., Beebe H.G.et al. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Circulation. 91:1995;566-579.
23. Wardlaw J.M., Warlow C.P., Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet. 350:1997;607-614.
24. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 81:1976;383-396.
25. Richman D.D., Fischl M.A., Grieco H.H.et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 317:1987;192-197.
26. Effectiveness of intravenous thrombolitic therapy in acute myocardial infarction. Lancet. 1:1986;397-402.
27. Marshall B.J., Armstrong J.A., McGechie D.B., Glancy R.J. Attempt to fulfill Koch's postulates for pyloric Campylobacter. Med J Aust. 142:1985;436-439.
28. Forbes G.M., Glaser M.E., Cullen D.J., Warren J.R., Christiansen K.J., Marshall B.J., Collins B.J. Duodenal ulcer treated with Helicobacter pylori eradication. seven-year follow-up Lancet. 343:1994;258-260.
29. Graham D.Y., Lew G.M., Klein P.D.et al. Effect of treatment of Helicobacter pylori infection in the long-term recurrence of gastric or duodenal ulcer. Ann Intern Med. 116:1992;705-708.
30. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
31. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 327:1992;227-233.